Catalent

Catalent Contract Manufacturing & Development (CDMO) Profile

ABOUT CATALENT

Catalent, Inc. is a global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,500 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply approximately 70 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of nearly 18,000 includes more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated nearly $4.3 billion in revenue in its 2023 fiscal year.

CDMO Services:
Small Molecule; Biologics; Cell & Gene Therapy Drug Product Formulation (FDF); Research & Development; Clinical Trials materials and logistics; Packaging; Regulatory Services; Analytical Development Inhalers; Liquids; Lyophilized amps/vials; Pre-Filled Syringes (PFS); Soft Gels; Solids; Sterile Ampoules; Sterile Vials

Year Founded: 2007

Head Office: Somerset, US

Number of Facilities: More than 10

Facility locations: Europe; Middle East; North America; South America; East Asia

Website: Visit the Catalent website

Linkedin: Connect on Linkedin